Market Place
Sourcing Support
BeyondSpring Announces 1st Patient Dosed Pembrolizumab,Plinabulin Plus Etoposide
25 Mar 2024 //
GLOBENEWSWIRE
Debiopharm doses first patient in Phase I trial of cancer combo therapy
30 May 2023 //
CLINICAL TRIALS ARENA
IMFINZI+chemotherapy tripled patient OS at 3 years in PIII trial in ES-SCLC
18 Sep 2021 //
BUSINESSWIRE
Roche celebrates European approval of Tecentriq combo in first-line lung cancer
06 Sep 2019 //
PHARMAFILE
H2-Pharma and Cheplapharm launch of Etopophos Injection
11 Jul 2019 //
THE PHARMALETTER
AstraZeneca Has Dazzled in Recent Cancer Trials, but Faces Stiff Competition
27 Jun 2019 //
BIOSPACE
Merck`s Keytruda gives BMS` Opdivo some company with small cell lung cancer nod
19 Jun 2019 //
FIERCE PHARMA
Imbrium Announces USFDA Orphan Drug Designation for Etoposide Toniribate
22 Feb 2019 //
BUSINESSWIRE
Mundipharma EDO: US FDA grants Orphan Drug Designation for etoposide toniribate
22 Feb 2019 //
BUSINESSWIRE
Mylan Lab`s Etoposide Receives Approval In US
23 Nov 2017 //
FDA
Mylan Lab’s Generic Etoposide Receives Approval In US
31 Oct 2017 //
FDA
Five drugs suspended after factory inspection
25 Oct 2017 //
FDA
Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
02 May 2015 //
FIERCE PHARMA MFG
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.